Substance Use and Misuse in Rural Areas – Resources
Selected recent or important resources focusing on Substance Use and Misuse in Rural Areas.
Cumulative Barriers to Retention in Methadone Treatment Among Adults From Rural and Small Urban Communities
Highlights a study on the barriers to retention in methadone treatment for opioid use disorder in rural and small urban communities. Breaks down data by participant characteristics and treatment barriers, such as housing instability, lack of transportation, and physical and mental health needs, among others.
Author(s): Emily Pasman, Rachel Kollin, Michael Broman, et al.
Citation: Addiction Science and Clinical Practice, 17, 35
Date: 07/2022
view details
Highlights a study on the barriers to retention in methadone treatment for opioid use disorder in rural and small urban communities. Breaks down data by participant characteristics and treatment barriers, such as housing instability, lack of transportation, and physical and mental health needs, among others.
Author(s): Emily Pasman, Rachel Kollin, Michael Broman, et al.
Citation: Addiction Science and Clinical Practice, 17, 35
Date: 07/2022
view details
The Rural Opioid Initiative Consortium Description: Providing Evidence to Understand the Fourth Wave of the Opioid Crisis
Highlights an initiative aimed at developing interventions to address rural opioid use. Collects data from rural areas in 10 states via surveys of people who use drugs and explores overlapping issues, such as other drug use, homelessness, and lack of access to treatment, among others.
Author(s): Richard A. Jenkins, Bridget M. Whitney, Robin M. Nance, et al.
Citation: Addiction Science and Clinical Practice, 17, 38
Date: 07/2022
view details
Highlights an initiative aimed at developing interventions to address rural opioid use. Collects data from rural areas in 10 states via surveys of people who use drugs and explores overlapping issues, such as other drug use, homelessness, and lack of access to treatment, among others.
Author(s): Richard A. Jenkins, Bridget M. Whitney, Robin M. Nance, et al.
Citation: Addiction Science and Clinical Practice, 17, 38
Date: 07/2022
view details
Geographic Trends in Opioid Overdoses in the US From 1999 to 2020
Results of a study examining trends in opioid-involved overdose death (OOD) rates in urban and rural counties. Explores OODs due to overprescription of opioids, use of heroin and illicit synthetic opioids such as fentanyl, and stimulants in combination with synthetic opioids. Features statistics with breakdowns by 6 levels of population density.
Author(s): Lori Ann Post, Alexander Lundberg, Charles B. Moss, et al.
Citation: JAMA Network Open, 5(7)
Date: 07/2022
view details
Results of a study examining trends in opioid-involved overdose death (OOD) rates in urban and rural counties. Explores OODs due to overprescription of opioids, use of heroin and illicit synthetic opioids such as fentanyl, and stimulants in combination with synthetic opioids. Features statistics with breakdowns by 6 levels of population density.
Author(s): Lori Ann Post, Alexander Lundberg, Charles B. Moss, et al.
Citation: JAMA Network Open, 5(7)
Date: 07/2022
view details
Barriers to Medications for Opioid Use Disorder in the Court System: Provider Availability, Provider "Trustworthiness," and Cost
Examines perceptions of medications for opioid use disorder (MOUD) availability, provider trustworthiness, and MOUD affordability based on a survey of 151 court team members in Florida. Discusses rates of court referral to MOUD treatment in cases involving opioid use disorder (OUD) and notes rural-specific barriers to MOUD referral.
Author(s): Fatema Z. Ahmed, Barbara Andraka-Christou, M.H. Clark, et al.
Citation: Health & Justice, 10, 24
Date: 07/2022
view details
Examines perceptions of medications for opioid use disorder (MOUD) availability, provider trustworthiness, and MOUD affordability based on a survey of 151 court team members in Florida. Discusses rates of court referral to MOUD treatment in cases involving opioid use disorder (OUD) and notes rural-specific barriers to MOUD referral.
Author(s): Fatema Z. Ahmed, Barbara Andraka-Christou, M.H. Clark, et al.
Citation: Health & Justice, 10, 24
Date: 07/2022
view details
Identifying Unique Barriers to Implementing Rural Emergency Department-Based Peer Services for Opioid Use Disorder Through Qualitative Comparison with Urban Sites
Study examining the implementation of emergency department-based interventions for opioid use disorder (OUD) in rural and urban areas based on interviews with programs in Indiana's Recovery Coach and Peer Support Initiative (RCPSI). Describes barriers to implementation for rural programs, including issues related to intervention characteristics, logistical challenges, and staffing issues.
Author(s): Dennis P. Watson, Monte D. Staton, Nicole Gastala
Citation: Addiction Science & Clinical Practice, 17, 41
Date: 07/2022
view details
Study examining the implementation of emergency department-based interventions for opioid use disorder (OUD) in rural and urban areas based on interviews with programs in Indiana's Recovery Coach and Peer Support Initiative (RCPSI). Describes barriers to implementation for rural programs, including issues related to intervention characteristics, logistical challenges, and staffing issues.
Author(s): Dennis P. Watson, Monte D. Staton, Nicole Gastala
Citation: Addiction Science & Clinical Practice, 17, 41
Date: 07/2022
view details
Fighting Fentanyl: The Federal Response to a Growing Crisis
Presents the U.S. Senate Committee on Health, Education, Labor, and Pensions (HELP) hearing on the government's response to the fentanyl crisis. Includes testimonies from the Substance Abuse and Mental Health Administration (SAMHSA), National Center for Injury Prevention and Control, Health Resources and Services Administration (HRSA), and the Office of National Drug Control Policy regarding current efforts to address the expanding use of fentanyl across the U.S.
Additional links: Carole Johnson Testimony, Christopher Jones Testimony, Kemp Chester Testimony, Miriam E. Delphin-Rittmon Testimony
Date: 07/2022
Sponsoring organization: Senate Committee on Health, Education, Labor & Pensions
view details
Presents the U.S. Senate Committee on Health, Education, Labor, and Pensions (HELP) hearing on the government's response to the fentanyl crisis. Includes testimonies from the Substance Abuse and Mental Health Administration (SAMHSA), National Center for Injury Prevention and Control, Health Resources and Services Administration (HRSA), and the Office of National Drug Control Policy regarding current efforts to address the expanding use of fentanyl across the U.S.
Additional links: Carole Johnson Testimony, Christopher Jones Testimony, Kemp Chester Testimony, Miriam E. Delphin-Rittmon Testimony
Date: 07/2022
Sponsoring organization: Senate Committee on Health, Education, Labor & Pensions
view details
Responding to a Surge in Overdose Deaths: Perspectives From US Syringe Services Programs
Highlights a study on the perspectives of syringe service program (SSP) leadership and staff regarding overdose deaths in the US. Bases conclusions on interviews done from February to March of 2021 and breaks down participant data by geographic region, distribution approach, and rurality, among others factors.
Author(s): Madeline C. Frost, Elizabeth J. Austin, Maria A. Corcorran, et al.
Citation: Harm Reduction Journal, 19, 79
Date: 07/2022
view details
Highlights a study on the perspectives of syringe service program (SSP) leadership and staff regarding overdose deaths in the US. Bases conclusions on interviews done from February to March of 2021 and breaks down participant data by geographic region, distribution approach, and rurality, among others factors.
Author(s): Madeline C. Frost, Elizabeth J. Austin, Maria A. Corcorran, et al.
Citation: Harm Reduction Journal, 19, 79
Date: 07/2022
view details
Urban–Rural Differences in Drug Overdose Death Rates, 2020
Examines 2020 drug overdose deaths by sex and type of drug, among other factors, with data broken down by rural versus urban county status. Includes a U.S. map that depicts if overall urban or rural counties in a state have a higher rate of age-adjusted overdose death.
Author(s): Merianne Rose Spencer, Matthew F. Garnett, Arialdi M. Miniño
Date: 07/2022
Sponsoring organization: National Center for Health Statistics
view details
Examines 2020 drug overdose deaths by sex and type of drug, among other factors, with data broken down by rural versus urban county status. Includes a U.S. map that depicts if overall urban or rural counties in a state have a higher rate of age-adjusted overdose death.
Author(s): Merianne Rose Spencer, Matthew F. Garnett, Arialdi M. Miniño
Date: 07/2022
Sponsoring organization: National Center for Health Statistics
view details
Barriers and Facilitators Associated With Establishment of Emergency Department-Initiated Buprenorphine for Opioid Use Disorder in Rural Maine
Presents a study on the barriers and facilitators for implementing programs that initiate buprenorphine treatment for patients with opioid use disorder (OUD) seeking care in critical access hospital (CAH) emergency departments (EDs) in rural Maine. Highlights findings of a survey of CAH ED directors on the challenges of implementing buprenorphine initiation programs.
Author(s): Noah K. Rosenberg, Alexander B. Hill, Lily Johnsky, et al.
Citation: Journal of Rural Health, 38(3), 612-619
Date: 06/2022
view details
Presents a study on the barriers and facilitators for implementing programs that initiate buprenorphine treatment for patients with opioid use disorder (OUD) seeking care in critical access hospital (CAH) emergency departments (EDs) in rural Maine. Highlights findings of a survey of CAH ED directors on the challenges of implementing buprenorphine initiation programs.
Author(s): Noah K. Rosenberg, Alexander B. Hill, Lily Johnsky, et al.
Citation: Journal of Rural Health, 38(3), 612-619
Date: 06/2022
view details
Introduction to Improving Telehealth and Virtual Care for Pain Management and Opioid/ Substance Use Disorder
Presents the proceedings of a meeting discussing the use of telehealth and virtual care to treat substance use disorder (SUD), opioid use disorder (OUD), and to monitor pain management. Highlights the effect the COVID-19 pandemic on telehealth use, regulation, and reimbursement. Features considerations for rural communities.
Date: 06/2022
Sponsoring organization: National Academy of Medicine
view details
Presents the proceedings of a meeting discussing the use of telehealth and virtual care to treat substance use disorder (SUD), opioid use disorder (OUD), and to monitor pain management. Highlights the effect the COVID-19 pandemic on telehealth use, regulation, and reimbursement. Features considerations for rural communities.
Date: 06/2022
Sponsoring organization: National Academy of Medicine
view details
Additional resources are available related to this guide. See the full list of resources by topic for:
- Alcohol use
- Behavioral health
- Behavioral health workforce
- Illicit drug use
- Prescription drug misuse
- Substance use and misuse
- Tobacco use
Last Updated: 4/1/2025